| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.015 | 1 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.0029 | 1 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.0077 | 1 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.0061 | 1 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |